A Trial of Fecal Microbiome Transplantation in Parkinson's Disease Patients
A Randomized, Double Blind, Placebo Controlled Multicenter Trial of Fecal Microbiome Transplantation Safety and Efficacy for Parkinson's Disease Patients with Abnormal Gut Microbiota Composition
Sponsor: Central Hospital of Paijat-Hame
This NA trial investigates Parkinson Disease and is currently completed. Central Hospital of Paijat-Hame leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Nov 2024 — Present [monthly]
Completed NA
-
Sep 2024 — Nov 2024 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Oct 2023 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jun 2022 — Oct 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 1 earlier version
-
May 2021 — Jun 2022 [monthly]
Recruiting NA
First recorded
Apr 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Central Hospital of Paijat-Hame
- Helsinki University Central Hospital
- Tampere University Hospital
- Turku University Hospital
- University of Aarhus
- University of Helsinki
For direct contact, visit the study record on ClinicalTrials.gov .